Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sintilimab plus apatinib and chemotherapy for HER-2 negative MSS advanced or metastatic gastric or gastroesophageal junction cancer; st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Apatinib (apatinib)
• Chemotherapy (chemotherapy)
• Sintilimab (sintilimab)

Snippet

Sponsor: Jiuda Zhao | Conditions: Gastric Cancer, Chemotherapy | Phase 2 | Status: UNKNOWN